A multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.
Modern Retina Spring 2022
In the face of the COVID-19 pandemic, the procedure required adjustments.
The implant achieves impressive efficacy and reduces treatment burden.
Investigational pipeline provides promise for an unmet need.
The first FDA-approved bispecific antibody for the eye targets two leading causes of vision loss.
Advertisement
Advertisement
Trending on Modern Retina
1
Frank Holz, MD, FEBO, FARVO, highlights new treatment developments at EURETINA
2
The Retina TL;DR: Advancing sustained VEGF suppression with EYP-1901 with Jay S. Duker, MD
3
Study finds retinal progenitor cell injections improve outcomes in rat model of diabetic retinopathy
4
